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glucocorticoids were extracted from adipose tissue samples using solid-phase extraction.
Estrogens were derivatized using 1-(5-fluoro-2,4-dinitrophenyl)-4-methylpiperazine (PPZ) and methyl iodide to generate a permanently charged molecule (MPPZ). Steroids were separated and quantified by LC-MS/MS. The limit of quantitation for the steroids was between 15 and 100 pg per sample. Accuracy and precision were acceptable (< 20%). Using this method, estradiol, estrone, cortisone and cortisol were quantified in adipose tissue from women with and without breast cancer. This novel assay of estrogens and glucocorticoids by LC-MS/MS coupled with derivatization allowed simultaneous quantification of a panel of steroids in human adipose tissue across the endogenous range of concentrations encountered in health and disease.
Abbreviations: 13 ]-cortisol; FA, Formic acid; GC-MS/MS, Gas chromatographytandem mass spectrometry; HPLC, High-performance liquid chromatography; IS, Internal standards; LC-MS/MS, Liquid chromatography-tandem mass spectrometry; LLE, Liquid-liquid extraction; LOQ, Limit of quantitation; LOD, Limit of detection; MeOH, Methanol; MPPZ, 1-(2,4-dinitro-5-fluorphenyl)-4,4-dimethylpiperazinium; MRM, Multiple reaction monitoring; MTBE, methyl t-butyl ether; OFN, Oxygen-free nitrogen; PPZ, 1-(2,4-dinitro-5-fluorphenyl)-4-J o u r n a l P r e -p r o o f
INTRODUCTION
Adipose tissue is an active endocrine organ and a site of storage for steroids due to their lipophilicity. We and others have described several steroid-converting enzymes localized in adipose tissue (1) and proposed their importance in modulating adipose tissue function e.g. adipocyte hypertrophy and lipid storage. Glucocorticoid and estrogen concentrations and their respective activation enzymes, 11β-hydroxysteroid dehydrogenase 1 (11βHSD1) and aromatase, are both increased in adipose tissue in obesity, although little is known about their interactions and cross-regulation (2) . Increases in estrogen concentrations in breast adipose in obesity may be of importance for local tumour growth (1) . Glucocorticoids can increase androgen-to-estrogen conversion in adipose tissue through activating the glucocorticoid response element on exon I.4 of the aromatase gene, a well-established mechanism (3) (Figure 1) . Accordingly, aromatase and 11βHSD1 expression in subcutaneous adipose tissue are positively associated (4) . However, evidence from rodent studies suggests that high estrogen concentrations inhibit the expression of 11βHSD1 (5) (6) (7) (8) . These apparently conflicting results warrant further study of adipose tissue steroid homeostasis by measurement of the active steroids rather than inferring function from transcript levels of the enzymes.
Accurate quantification of steroid hormones in adipose tissue is difficult. Mass spectrometry is the gold standard analytical approach (9), but adipose tissue presents significant challenges as a matrix. High concentrations of lipidic compounds sharing similar physico-chemical properties to those of steroids can cause substantial ion J o u r n a l P r e -p r o o f suppression and interfere with the steroid signal. Removing interfering compounds may help increase signal to noise of the peaks of the steroids of interest, but one must also consider the concomitant signal loss that may occur during processing. Of particular note, the use of different sample preparation and analytical approaches for specific steroid hormones makes it difficult to allow the direct comparison among studies (2, (10) (11) (12) (13) .
In the context of research, curation of large biobanks of human adipose samples is difficult and collection of sufficient clinical material (e.g. more than 1 g) per patient in various disease states is challenging, especially in fat depots of interest (visceral, breast).
Immunoassays such as radioimmunoassays and enzyme-linked immunosorbent assays, have the advantage of high sensitivity and so do not use large amounts of samples, but they can be limited by specificity (9, 14) . Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is an attractive alternative as the analytical technique for development of an extraction and quantification protocol of steroids in adipose tissue, as it is already the gold standard for analysis of steroid panels in plasma (15, 16) . It typically offers shorter run times per sample compared to gas chromatography-tandem mass spectrometry (GC-MS/MS). Assays based on LC-MS/MS had previously been used for quantifying glucocorticoids in adipose tissue in our laboratory (17), but were not optimized for estrogens.
Our aim was to develop a new LC-MS/MS method to detect and quantify estrogens (17β-estradiol (E2) and estrone (E1)) as well as glucocorticoids (cortisol, cortisone) in adipose tissue. Considering the limited amount of tissue available, derivatization of estrogens was J o u r n a l P r e -p r o o f Laforest et al. 2019, page 8 deemed necessary as E2 and E1 are present in 10-100-fold lower concentrations than glucocorticoids, in plasma and adipose tissue (2, (10) (11) (12) (13) (15) (16) (17) , and have a poor ionization profile. We adapted a validated, highly efficient derivatization approach for estrogens in serum developed by Nishio et al. (18) for use in adipose, drawing from modifications we had made to the method to quantify a wider panel of estrogen in plasma (19) .
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MATERIALS AND METHODS

Standards and solvents
E1, E2, and 17α-estradiol (17α-E2) were obtained from Steraloids, Inc (Newport, USA). 
Adipose tissue samples
Adipose tissue samples for method development and validation originated from breast adipose tissue obtained from women undergoing reduction mammoplasty. Aliquots (~200 mg) were stored at -80°C. The study protocol was approved by the Research Ethics Committees of Laval University Medical Center (DR-002-136). All patients signed a written, informed consent prior to surgery.
Standard solutions
Glucocorticoids, estrogens and IS (1 mg) were dissolved in MeOH (1 mL) and stored at -80°C. Working solutions (0.0001 to 1000 pg/mL) were prepared by serial dilution on the day of use. The supernatant was transferred into a new glass tube and reduced to dryness under oxygen-free nitrogen (OFN, 60°C). Samples were resuspended in aqueous MeOH (30% v/v, 5 mL). Solid-phase extraction was carried out after conditioning the C18 SepPak columns (12cc, 2g; Waters, Wilmslow, UK; MeOH (2 x 10 mL), followed by water (2 x 10 mL)). The adipose extract was loaded, and the column washed with water (10 mL) followed by aqueous MeOH (5%, 10 mL). Steroids were eluted using J o u r n a l P r e -p r o o f
Extraction method
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MeOH:CH3CN (1:1, 10 mL) into clean glass vials. The eluate was dried under OFN before derivatization of the estrogens.
Generation of MPPZ derivatives
MPPZ derivatives were prepared as previously reported (19) . Briefly, acetone (70 µL), sodium bicarbonate (10 µL, 1 M), and PPZ (10 µL in acetone, 1 mg/mL) were added to the standard/extracted sample and incubated (1 h, 60°C). The sample was reduced to dryness under OFN, followed by addition of iodomethane (100 µL) to the residue (2 h, 40°C) (19) . After reduction to dryness under OFN, samples were then dissolved in LC- Figure 2 (18, 19).
MS grade water:acetonitrile (70 µL; 70:30). A schematic representation of the generation of MPPZ derivatives of E1 and E2 is shown in
Instrumentation
Cortisone, cortisol, E1 and E2 were quantified by LC-MS/MS, using a UHPLC Shimadzu Nexera 2 system (Kyoto, Japan) coupled to a Sciex QTRAP ® 6500+ (SCIEX, Warrington, UK) equipped with a Turbospray interface and operated with Analyst software v1.6.3. MS conditions are described in Table 1 , with ion spray voltage (5500 V) and source temperature (500°C) and GS1 (414 kPa) and GS2 (276 kPa). The compounddependent parameters are described in Table 1 . Optimal MS/MS precursor-product transitions and voltages were used, following direct infusion of individual solutions, as previously described (19, 23) .
Chromatographic conditions
Standards of glucocorticoids and MPPZ estrogens were injected individually to confirm chromatographic resolution using an ACE 2 Excel C18-PFP (150 × 2.1 mm, 2 μm, ACT Technologies, Aberdeen, UK) column.
At a constant flow rate of 0.5 mL/min, the chromatography conditions began with 90:10 water with 0.1% FA (solution A) and acetonitrile with 0.1% FA (solution B) which was maintained for 1 minute. This was followed by an 11-minute linear gradient to 50% B, which was maintained for 2 minutes, before returning to 10% B by 15 minutes, again maintaining for 3 minutes to re-equilibrate. The column and auto-sampler temperatures were 40°C and 15°C, respectively. Injection volume was 30 µL.
Assay validation
Apparent extraction efficiency
Different compositions, volumes and types of elution solvent were tested, namely, DCM, MeOH and MeOH:acetonitrile (1:1). Recoveries of steroids from adipose tissue and standard solutions were assessed by comparison of signal intensities between samples pre-and post-spiked with IS (5 ng; before homogenization and after solid-phase extraction respectively).
Assessment of matrix effects
Ion suppression was assessed by comparing signal intensity of IS post-spiked into extracted adipose tissue samples with that of aqueous steroid solutions following J o u r n a l P r e -p r o o f derivatization. To reduce ion suppression without compromising recovery, washes with MeOH (0 to 30%) were assessed. A hexane wash was also tested.
Specificity
Extracted ion chromatograms were carefully examined according to the retention times of IS for interferences by other endogenous compounds in adipose tissue extracts, which could introduce inaccuracies in quantitation.
Linearity
Blank samples and aliquots containing estrogens (5, 7.5, 10, 15, 25, 50, 100, 200, 500, 1000 pg/sample), glucocorticoids (50, 75, 100, 150, 250, 500, 1000, 2000, 5000, 10000 pg/sample) and combined IS (5 ng) were analyzed by LC-MS/MS. Calibration curves were plotted as the peak area ratio (standard/IS) versus amount of analytes (glucocorticoids or estrogens). Calibration lines of best fit were acceptable if the regression coefficient, r, was > 0.99. Weightings of 1, 1/x and 1/x 2 were compared and 1/x weighting selected to reduce errors at low amounts of analyte.
Accuracy and precision
The precision and accuracy were assessed using standard solutions prepared on the same and different days. The precision was calculated as the Relative Standard Deviation (RSD) (standard deviation/mean x 100), and % accuracy was the Relative Mean Error J o u r n a l P r e -p r o o f
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(RME) ((mean measured value -theoretical value)/theoretical value x 100); precision was accepted with RSDs 20% and RME 100 ± 20% (24).
Limit of detection and quantitation
The signal/noise ratio (SNR) was calculated from peak areas of steroids and adjacent background noise (over the same time window as the peak width). The limits of detection were assigned at a SNR ≥ 3 (24).
Replicate aliquots (7.5, 15, 25, 50, 1000 pg/sample and 0.075, 0.15, 0.25, 0.5, 10 ng/sample) of estrogens and glucocorticoids, respectively and IS were prepared as above and analyzed. The LOQ was calculated as the amount affording precision and accuracy of ~20% or less (24).
Method application
The presence of glucocorticoids and estrogens was assessed, and their amounts quantified in breast adipose tissue from healthy women (n = 6) and breast cancer patients (n = 17) using the validated method.
RESULTS AND DISCUSSION
Analysis of steroids in small biopsy samples of adipose tissue from clinical studies is desirable. Here we report a method allowing both glucocorticoids and estrogens to be assessed in single adipose tissue samples, applied here to breast tissue in the setting of cancer. Challenges existed in combining these steroids in one assay due to different dynamic ranges in concentration, as well as different chemical properties between phenolic and non-aromatic steroids. The use of MPPZ derivatization enabled detection of estrogens, without compromising quantitation of glucocorticoids.
Extraction
Both liquid-liquid extraction (LLE) followed by solid-phase extraction (SPE) or SPE on its own have been used to recover estrogens and glucocorticoids from adipose tissue samples in previous publications (2, (10) (11) (12) 25) . SPE was our favoured approach here, as extraction column technologies have been developed to reduce ion suppression particularly with complex matrices. Although analyte specific, LLE presents drawbacks with reports of high variability across experimenters due to manual errors (25) .
Alternative conditions were tested to improve recovery of the main analytes of interest i.e. cortisone, cortisol, E1 and E2. Homogenization solutions of either EtOAc, EtOH:EtOAc (1:1), Et2O:EtOAc (2:1) or water were tested to solubilize the steroids.
When water was used, this was then followed by LLE comparing three different organic solvent solutions used in previous publications with estrogen extraction protocols:
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Et2O:EtOAc (2:1) (27), Et2O (28) or MTBE (20) . Under these circumstances, poor recovery rates were achieved; < 15% for 13 C3-E2 and < 50% for 13 C3-E1. Recovery for D4-F from the homogenate into EtOAc was highest (60-70%) as previously reported (17, 23) . Addition of EtOH with EtOAc lowered the recovery for cortisol (D4-F) only slightly (around 5%), but increased recovery of 13 C3-E2 and 13 C3-E1 significantly. The best recovery rate for both estrogens was achieved using EtOH:EtOAc (1:1)(> 60%).
Following homogenization, shattering the tissue by dripping it through acetic acid, and steps involving sonication and centrifugation were also assessed to enhance extraction efficiency (17, 23) . Sonication and longer centrifugation time improved recovery by 5-10%, but "acetic acid dripping" of tissue led to a loss of the estrogens (17, 23) . Final sample clean-up by SPE was assessed comparing reversed phase matrices with polymeric sorbent (Oasis HLB®). As previously reported, reversed-phase C18 (BondElut® (2g, 12cc) and Sep-Pak® (2g, 12cc) C18 columns) showed better recovery rate and lower matrix effect for steroids isolated from adipose when compared to polymeric sorbents, unlike from plasma (19, 20, 29) . In our hands, recovery was not different across the two reversed-phase C18 columns tested, although sample preparation was quicker with SepPak® compared to BondElut®, due to a faster flow.
To decrease ion suppression by cleaning the sample further, a variety of washing steps with Sep-Pak® columns were tested, aiming to maintain recovery. Washes tested included, water (2 x 10 mL); water (1 x 10 mL) followed by aqueous 5%, 10%, 20% or 30% MeOH (1 x 10 mL); water (1 x 10 mL) followed by aqueous 5% MeOH (1 x 10 mL)
Laforest et al. 2019, page 17
and hexane (1 x 10 mL); and finally, water (1 x 10 mL) followed by hexane (1 x 10 mL). (17, 23) , and using MeOH:CH3CN (1:1) led to a further loss of ~5% but this was deemed acceptable for the combined assay, given that glucocorticoids were more abundant. Of note, measurements of recovery were increased when collection tubes were preconditioned with the elution solvent (K. Soma, personal communication, 2018).
Chromatographic conditions
Chromatographic conditions were based on those developed by Denver and collaborators (19) for the analysis of estrogens in plasma. Using the same gradient and column, we J o u r n a l P r e -p r o o f could not separate cortisol and cortisone, which was necessary as cortisol may suffer isobaric interference from natural isotopologues of cortisone. Following changes to the gradient, the two glucocorticoids were separated, without affecting the separation of derivatized estrone and estradiol (Figure 3) . The gradient was achieved more rapidly and maintained for a shorter period than Denver et al. (19) , who also analyzed estrogen metabolites. Increasing the column temperature to 40°C increased the resolution of the glucocorticoids. Of note, initially we observed a shift in the retention time, tracked by the isotopically labelled IS, between extracts of standards and those of adipose tissue, but this drift was eliminated by addition of high organic washes (95% CH3CN) after four-five adipose tissue samples and was most likely to be due to build-up of lipid residues in the column. However, we cannot rule out that this is also due to build-up of the derivatizing agents as we were faced with similar issues with plasma samples (19) . To further 
Specificity
Baseline chromatographic separation of both glucocorticoids and derivatives of estrogens was achieved using aqueous standards (Figure 3) . Stable isotope-labelled E2, E1 and cortisol were selected from previous applications (19, 23) . Isotopically labelled IS can J o u r n a l P r e -p r o o f both introduce and suffer from isobaric interferences, but this was pre-empted in the design of the chromatographic method. We also confirmed that inactive 17α-E2 does not elute at the same time as active 17β-E2. The use of three stable isotope standards allowed for confidence in identification in the biological matrix. When applied to adipose tissue samples, the chromatographic regions close to the retention time of the analytes were free from any interferences which may disrupt peak shape (Figure 4) . Of note, some may be added should further reassurance of specificity be required.
Linearity
Linear standard curves of cortisone, cortisol, E1-MPPZ and E2-MPPZ were generated ( Figure 5) . A mean r-value > 0.99 was achieved for analytes with a weighting of 1/x ( Table 2 ). The linear ranges were similar to those used in other methods quantifying those steroids in human adipose tissue, albeit not in combination (2, 13).
Accuracy and precision
The values for intra-assay precision and accuracy (Table 3 ) were acceptable (< 20% RSD for precision and < ± 20% accuracy) at low and high points of the calibration curve.
Cortisone showed less precision and accuracy than cortisol, attributed to the use of J o u r n a l P r e -p r o o f cortisol IS (D4-F) for cortisone and not labelled cortisone IS. D8-cortisone is available commercially and could be introduced in the future. The precision and accuracy of the upper cortisone points could be improved by use of an unweighted standard curve.
Limits of detection and quantitation
The LODs for the four analytes of interest are shown in Table 2 . We report an LOQ of 15 pg and 25 pg on column for E1-MPPZ and E2-MPPZ, respectively ( Table 2) .
Adjusting for a generic mass of 200 mg of adipose tissue, this equates to ~275 pmol/kg and 459 pmol/kg. This is a higher LOQ for E2 than the ones reported in negative ESI (11, 12) and in GC-MS/MS (13). However, those other methods are not directly comparable as they did not combine estrogen and glucocorticoid extraction and thus could focus the instrumental conditions to a greater degree. Due to the permanently charged moiety of the derivative produced, we used ESI in positive mode which has inherently more noise than negative mode (11, 12) . Positive ESI was necessary for the combined approach as glucocorticoids would not readily ionize in negative mode. Care was taken to ensure that cortisone and cortisol were unaffected by the derivatization process as expected, because the nucleophilic substitution with PPZ in the presence of a base requires an activated phenolic hydroxyl group. Aliphatic hydroxyl groups in E2, cortisone and cortisol do not react with analogues of Sanger's reagent such as PPZ (18) . In screening experiments, we did not see change in amount of D4-F measured in derivatized vs underivatized adipose extracts or aqueous standard solutions or any detriment to its SNR. As reported by
Hennig et al., the use of only one extraction column may also explain the lower sensitivity of our combined method (13) .
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Despite slightly higher LOQs, our method achieved higher recovery, especially for E2, as well as reduced matrix effects, leading to quantifiable E2 in breast adipose tissue, even in postmenopausal women. Further reductions in ion suppression were difficult to achieve because upon assessment of elution fractions (1 mL), we found that components causing ion suppression occurred primarily in the same fraction that contained the estrogens. In summary, it is unlikely that adding more steps during sample preparation by SPE would J o u r n a l P r e -p r o o f
Method application
The method was applied to samples from healthy women undergoing reduction mastectomy and breast cancer patients undergoing partial mastectomy. We were able to detect and quantify estrogens in more than 90% of our samples using around 200 mg of adipose tissue. Cortisol was detected in all breast adipose tissue samples and cortisone in most. Of note, cortisone was undetected in 5 samples, 4 of which were from women without breast cancer, although the number of samples is too small to draw firm conclusions and not the purpose of this report. A few samples generated data higher than the ULOQ, suggesting that validation of a higher point would be advisable moving forward. Data points higher than the ULOQ were observed from breast adipose tissue from both control women and cancer patients.
Calculated amounts of cortisone and cortisol as well as estrone were in the same range as previously reported in subcutaneous and visceral adipose tissue (2) or in breast adipose tissue (2, 13) . E2 levels were higher than expected by 10-fold, but this is in comparison with a very limited number of studies available in breast adipose tissue (2, 13) .
Interestingly, when E2 levels in breast adipose tissue are reported, levels often fall below LOQ and LOD, which was not the case with our assay. For example, Hennig and collaborators reported a LOD of 50 pg/g for all estrogens but reported a median adipose tissue concentration of 40 pg/g for E2 (13) .
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